The association of clinical outcome with right atrial and ventricular remodelling in patients with pulmonary arterial hypertension: study with real-time three-dimensional echocardiography.

AIMS Right atrial (RA) dilatation may be important for patients' outcome in pulmonary arterial hypertension (PAH). The aim of this study was to examine the longitudinal RA and right ventricular (RV) remodelling in PAH patients using real-time three-dimensional echocardiography (3DE) and their relation to clinical outcome. METHODS AND RESULTS Sixty-two consecutive PAH patients were studied and compared with a control group of 30 healthy volunteers. RA and RV sphericity indices were measured with 3DE. RV ejection fraction (RVEF), RA volume (RAvol), and the quantification of jet area of tricuspid regurgitation (TR) were measured. Two observers were used for reproducibility assessment. The geometrical change of RA and RV was assessed in relation to clinical outcome, as defined by the increase of functional class or admission to the hospital due to right heart failure. Over 1 year of follow-up, there was significant increase of RA sphericity index (0.85±0.16 vs. 1.2±0.24, P<0.01), RV dilatation (RV sphericity index 0.71±0.07 vs. 0.98±0.04, P<0.01), as well as deterioration of RV systolic function (RVEF 33±8.2 vs. 28±7.6%, P<0.01). Twenty-three patients (37%) had a clinical deterioration within 1 year. An increase of RA sphericity index>0.24 predicted clinical deterioration with a sensitivity of 96% and a specificity of 90% [area under the curve (AUC) 0.97]. RV sphericity index was less sensitive (70%) and specific (62%) in predicting clinical deterioration (AUC 0.649). The deterioration in RVEF had a sensitivity of 91.1% and a specificity of 35.3% (AUC 0.479) in predicting clinical deterioration. The dilatation of RA>14 mL over 1 year had high sensitivity at 82.6% but low specificity at 30.8% in predicting clinical deterioration. CONCLUSION PAH leads to RA and RV dilatation and functional deterioration which are linked to an adverse clinical outcome. 3DE measurement of RA sphericity index may be a suitable index in predicting clinical deterioration of PAH patients.

[1]  J. Zamorano,et al.  European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease). , 2010, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[2]  Alberto Milan,et al.  Echocardiographic indexes for the non-invasive evaluation of pulmonary hemodynamics. , 2010, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[3]  H. Willens,et al.  Effects of age and pulmonary arterial hypertension on the different phases of right atrial function , 2008, The International Journal of Cardiovascular Imaging.

[4]  L. Tarantini,et al.  Right atrial size and function in patients with pulmonary hypertension associated with disorders of respiratory system or hypoxemia. , 2007, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[5]  N. Zafrir,et al.  Use of noninvasive tools in primary pulmonary hypertension to assess the correlation of right ventricular function with functional capacity and to predict outcome , 2007, The International Journal of Cardiovascular Imaging.

[6]  Victor Mor-Avi,et al.  Three-dimensional echocardiography: the benefits of the additional dimension. , 2006, Journal of the American College of Cardiology.

[7]  Young‐Bae Park,et al.  Determinants of the severity of functional tricuspid regurgitation. , 2006, The American journal of cardiology.

[8]  Cheuk-Man Yu,et al.  Effect of age and heart rate on atrial mechanical function assessed by Doppler tissue imaging in healthy individuals. , 2006, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[9]  Thomas H Marwick,et al.  Use of real-time three-dimensional echocardiography to measure left atrial volume: comparison with other echocardiographic techniques. , 2005, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[10]  P. Steendijk,et al.  Right Atrial and Ventricular Adaptation to Chronic Right Ventricular Pressure Overload , 2005, Circulation.

[11]  G. Koch,et al.  Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension. , 2002, Journal of the American College of Cardiology.

[12]  B Wranne,et al.  Normal regional right ventricular function and its change with age: a Doppler myocardial imaging study. , 2000, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[13]  D. King,et al.  Left and right atrial volume by freehand three-dimensional echocardiography: in vivo validation using magnetic resonance imaging. , 2000, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[14]  L. Weinert,et al.  Effect of Age, Heart Rate and Tricuspid Regurgitation on the Doppler Echocardiographic Evaluation of Right Ventricular Diastolic Function , 2000, Cardiology.

[15]  H. Ihlen,et al.  Left atrial volumes assessed by three- and two-dimensional echocardiography compared to MRI estimates , 1999, The International Journal of Cardiac Imaging.

[16]  G. Koch,et al.  Effects of Long-term Infusion of Prostacyclin (Epoprostenol) on Echocardiographic Measures of Right Ventricular Structure and Function in Primary Pulmonary Hypertension , 1997 .

[17]  M. Dolgin,et al.  Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels , 1994 .

[18]  L. Dell’Italia,et al.  The right ventricle: anatomy, physiology, and clinical importance. , 1991, Current problems in cardiology.

[19]  E H Bergofsky,et al.  Survival in Patients with Primary Pulmonary Hypertension: Results from a National Prospective Registry , 1991 .

[20]  N. Schiller,et al.  Atrial volume in a normal adult population by two-dimensional echocardiography. , 1984, Chest.

[21]  G. Rowe,et al.  Tricuspid Insufficiency: A Study of Hemodynamics and Pathogenesis , 1972, Circulation.

[22]  S. Solomon,et al.  GUIDELINES AND STANDARDS , 2010 .

[23]  D. O’Regan,et al.  Right ventricular remodelling in pulmonary arterial hypertension with three-dimensional echocardiography: comparison with cardiac magnetic resonance imaging. , 2010, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[24]  J. D. De Muth,et al.  Overview of biostatistics used in clinical research. , 2009, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[25]  J. E. D. Muth.  Overview of biostatistics used in clinical research , 2009 .

[26]  T. Manolio,et al.  Left atrial volume, geometry, and function in systolic and diastolic heart failure of persons > or =65 years of age (the cardiovascular health study). , 2006, The American journal of cardiology.

[27]  G. Dreyfus,et al.  Secondary tricuspid regurgitation or dilatation: which should be the criteria for surgical repair? , 2005, The Annals of thoracic surgery.

[28]  P Toutouzas,et al.  A clinical appraisal of left atrial function. , 2001, European heart journal.

[29]  D. King,et al.  Three-dimensional echocardiography. Advances for measurement of ventricular volume and mass. , 1994, Hypertension.